Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basic transcription factor 3 pseudogene 13 (BTF3P13) is a processed pseudogene located on chromosome 4q23 in humans. While it is homologous to the basic transcription factor 3 (BTF3) gene, BTF3P13 lacks coding potential and does not produce a functional protein product. As a pseudogene, it is not involved in biological pathways, does not serve as a therapeutic target, and has no known implications for disease or clinical biomarkers. There is no evidence in authoritative gene databases or the biomedical literature to suggest this pseudogene produces functional RNA or protein, nor does it fall into standard categories relevant for drug targeting or molecular therapeutics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic transcription factor 3 pseudogene 13 (BTF3P13).